Most new cancer medicines are precision medicines, that targets specific biomarkers. These can be highly effective, but they apply to relatively small patient groups, so cancer care is increasingly approached as a collection of rare diseases.
Better data standards and data quality enable clinical trials and better medicines for Irish cancer patients. More cancer trials, not only give patients faster access to new medicines but Cancer Trials Ireland emphasise they are also a vital part of care planning, as they provide staff training in new medicines.
Training so staff are prepared and can plan for new medicines, develop the specialised treatment protocols, recognise and plan for adverse events or side events.
Medical research embedded in care delivered pilots of new approaches that enable a health service to learn, develop, improve and better meet patient needs.
Lynch Syndrome Ireland 